Alnylam Pharmaceuticals
ALNY
#873
Rank
S$37.18 B
Marketcap
S$277.87
Share price
-1.01%
Change (1 day)
-50.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company